Hedge fund RTW under SEC investigation over Masimo proxy battle
RTW Investments, a $6.5bn hedge fund focused on investment in the life sciences sector, is under investigation by the Securities and Exchange Commission (SEC) for its role in a contentious proxy fight involving medical technology company Masimo Corp, according to

